A
Alector
AgeTech
About
Alector is a biotechnology company focused on developing therapies targeting neuroinflammation and neurodegeneration associated with aging-related cognitive decline. The company leverages immunology and genetics to create treatments aimed at extending healthspan and improving quality of life for older adults.
Is this your company?
Claim this listing to update your profile, add your logo, and reach buyers searching for AgeTech.
Key facts
FundingPrivate
SectorAgeTech
Are you Alector?
Claim your profile
Upgrade to Premium for a full profile, featured badge, logo, and contact button.
Get premium listing →